Skip to main content

Table 1 Groups of ICR mice and vaccination program

From: A prospective CSFV-PCV2 bivalent vaccine effectively protects against classical swine fever virus and porcine circovirus type 2 dual challenge and prevents horizontal transmission

Groups and vaccines

Immunization

CSFV-PCV2 bivalent vaccine (n = 5)

Intraperitoneally immunized (0.5 mL/dose) two doses at 6, 8 weeks of age

Placebo (n = 5)

Intraperitoneally immunized (0.5 mL/dose) two doses at 6, 8 weeks of age